//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दी
| 31 October, 2020, 09:11 PM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Alkem Laboratories Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 30 Oct, 2020, 03:57 PM IST
    2634.30

    Today's Change

    -36.50 (-1.37%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    25,733

    Open

    2688.20

    Prev. Close

    2670.80

    Day's Trend

    Low
    2620.00
    High
    2697.70
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)2.00
    • EPS-TTM (Rs.)114.05
    • BV/share (₹)527.66
    • 52Wk L/H1881.30/ 3090.00
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News
    Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
    Alkem Laboratories Ltd.Board Meeting Intimation for Notice Of Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On 06Th Nov...| Announcement
    Alkem Laboratories Ltd.Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2...| Announcement
    Alkem Laboratories Ltd.Shareholding for the Period Ended September 30, 2020| Announcement
    Alkem Laboratories Ltd.Statement Of Investor Complaints For The Quarter Ended September 2020| Announcement
    Alkem Laboratories Ltd.Compliances- Compliance Certificate For The Period Ended September, 2020.| Announcement
    Alkem Laboratories Ltd.Closure of Trading Window| Announcement
    Alkem Laboratories Ltd.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
    Alkem Laboratories Ltd.Shareholder Meeting / Postal Ballot-Scrutinizers Report| Announcement
    Alkem Laboratories Ltd.Shareholder Meeting / Postal Ballot-Outcome of AGM| Announcement
    Alkem Laboratories Ltd.Closure of Trading Window| Announcement
    Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
    Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
    Alkem Laboratories Ltd.Financial Results For The Quarter Ended 30Th June 2020| Announcement
    Alkem Laboratories Ltd.Outcome Of The Board Meeting Dated 7Th Aug 2020| Announcement
    Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
    Alkem Laboratories Ltd.Board Meeting Intimation for Notice Of Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On 07Th Aug...| Announcement
    Alkem Laboratories Ltd.Compliance Status Certificate (in terms of SEBI Exemption Order) for the financial year ended March 31, 2020| Announcement
    Alkem Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Alkem Labs Q3: Net profit up 90% to Rs 390 crore| News

    Alkem Laboratories Ltd. Share Price Updates

    Alkem Laboratories Ltd. share price down by -1.37% from its previous close of Rs 2670.80. Alkem Laboratories Ltd. stock last traded price is 2634.30
    Alkem Laboratories Ltd. Share Price
    Value
    Today/Current/Last
    2634.30
    Previous Day
    2670.80
    What's your view on Alkem Laboratories for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Alkem Laboratories Ltd.

    Alkem Laboratories Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    2,003.49
    -2.22
    8.33
    0.00
    7585.25
    Other Operating Income
    0.00
    0.00
    0.00
    -0.72
    118.06
    Operating Profit
    533.18
    75.95
    101.58
    -14.20
    2526.83
    Other Income
    43.50
    58.35
    149.00
    0.00
    153.79
    EBITDA
    576.68
    74.49
    104.52
    -14.20
    2526.83
    Interest
    17.10
    20.85
    6.08
    0.00
    102.00
    Depreciation
    66.83
    -17.54
    19.70
    0.00
    495.92
    Tax
    69.56
    58.96
    206.03
    -110.66
    305.90
    Net Profit
    422.01
    123.56
    127.54
    -1655.60
    780.58
    EPS (₹)
    35.30
    123.56
    127.60
    -10.81
    68.30

    Alkem Laboratories Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    2634.30
    -1.37
    1.28
    -5.17
    3.49
    33.25
    41.72
    0.00
    909.25
    -1.68
    -8.29
    -9.74
    2.12
    24.56
    -11.37
    -52.86
    474.80
    1.06
    -2.19
    -1.63
    7.57
    53.31
    -22.79
    -52.11
    772.65
    0.65
    -1.30
    -2.99
    -5.86
    66.88
    0.72
    -7.57
    417.70
    1.59
    -1.56
    5.73
    14.23
    67.05
    -16.17
    0.22
    1573.15
    -3.90
    -2.04
    -2.51
    4.02
    53.43
    27.34
    1.53
    964.60
    -0.57
    -0.94
    2.83
    -2.22
    76.39
    87.70
    42.08
    2566.85
    1.88
    -6.11
    -8.33
    5.30
    45.40
    102.27
    66.55
    534.95
    -0.59
    0.08
    -3.26
    13.38
    62.03
    110.86
    193.93
    2313.10
    -1.54
    6.33
    6.77
    32.52
    137.33
    333.77
    196.87
    1000.55
    -1.22
    0.59
    -1.42
    3.65
    14.96
    115.02
    290.84
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Alkem Laboratories Ltd Risk Return Comparison

    with peersNew

    Alkem Laboratories Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Alkem Laboratories Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    18.29
    6.15
    -97.73
    37.52
    Return on Assets (%)
    11.64
    4.29
    -51.80
    37.98
    Return on capital Employed (%)
    10.69
    5.75
    -86.49
    32.77
    Fixed Assets Turnover (x)
    1.16
    0.43
    -36.70
    3.05
    Profitability and Growth
    Gross Profit Margin (%)
    14.62
    -3.48
    -831.69
    43.32
    Operating Profit Margin(%)
    17.65
    3.00
    -802.77
    46.18
    Net Profit margin (%)
    13.50
    -9.07
    -653.62
    38.01
    Financial Strength
    Liquidity
    Quick Ratio (x)
    1.86
    2.00
    0.08
    37.52
    Current Ratio (x)
    3.25
    2.77
    0.21
    37.52
    Cash ratio (x)
    0.55
    0.24
    0.00
    2.43
    Solvency
    Debt Equity Ratio (x)
    0.03
    0.24
    0.00
    3.08
    Coverage Ratios
    Cash flows to long term debt (x)
    1.19
    2.78
    0.00
    24.88
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Alkem Laboratories Ltd Share Holding as on 30-09-2020

    CategoryNo. of sharesPercentage
    Promoters74,643,84962.43
    ForeignInstitutions4,689,5483.92
    NBanksMutualFunds9,197,5977.69
    Others748,5210.63
    GeneralPublic24,069,05120.13
    FinancialInstitutions6,216,4345.20

    MF Ownership Of Alkem Laboratories Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    SBI Equity Hybrid Direct-G
    Portfolio as on 30-09-2020
    Hybrid: Aggressive Hybrid
    1262000
    0.00%
    1.12%
    350.58
    SBI Long Term Equity Fund Direct-G
    Portfolio as on 30-09-2020
    Equity: ELSS
    510000
    0.00%
    1.91%
    141.68
    Equity: Sectoral-Pharma
    388462
    11.65%
    5.43%
    107.91

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Alkem Laboratories Ltd.

    Alkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 31497.01 Crore) operating in Pharmaceuticals sector.

    Alkem Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6534.80 Crore to Sales Value (97.86 % of Total Sales), Other Operating Revenue which contributed Rs 65.11 Crore to Sales Value (0.97 % of Total Sales), Export Incentives which contributed Rs 62.89 Crore to Sales Value (0.94 % of Total Sales), Scrap which contributed Rs 8.65 Crore to Sales Value (0.12 % of Total Sales), Royalty Income which contributed Rs 3.89 Crore to Sales Value (0.05 % of Total Sales) and Subsidy which contributed Rs 1.74 Crore to Sales Value (0.02 % of Total Sales)for the year ending 31-Mar-2020.

    For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 2003.49 Crore, down -2.22 % from last quarter Sales of Rs 2048.99 Crore and up 8.33 % from last year same quarter Sales of Rs 1849.50 Crore Company has reported net profit after tax of Rs 423.19 Crore in latest quarter.

    The company’s top management includes Dr.Dheeraj Sharma, Ms.Sangeeta Singh, Mr.Sarvesh Singh, Mr.Sandeep Singh, Mr.Samprada Singh, Mr.Ranjal Laxmana Shenoy, Mr.Mritunjay Kumar Singh, Mr.Dhananjay Kumar Singh, Mr.Basudeo N Singh, Mr.Balmiki Prasad Singh, Mr.Arun Kumar Purwar, Mr.Akhouri Maheshwar Prasad, Ms.Sudha Ravi. Company has BSR & Co. LLP as its auditors. As on 30-09-2020, the company has a total of 119,565,000 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors